Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Follicular
×
Anti-Infective Agents, Local
×
Clear all
Filters
3
NCT01313221
2017-03-15
REFINE
Amgen
Phase 3
Completed
310 enrolled
32 charts